Healthy participants
Conditions
Interventions
Group 1: Visual acuity measurement uncorrected, best corrected and with retinal projection spectacles ('Maxwellian View' principle)
Orthoptic examination of doublevision
Sponsors
Universitätsklinikum Essen
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 18 years and more Refractive Errors: -8 Diopters till +6Dpt with or without astigmatism
Exclusion criteria
Exclusion criteria: Age 60 years Diseased optical nerve, Cornea, lens, or Sklera Amblyopia, Strabism, Nystagmus Intake of pharmaceuticals that might sensitize the Retina: Chloroquin, Hydroxychloroquin, Mefloquin, Vigabatrin, Deferoxamin, Chlorpromazin, Clofazimin, Cisplatin, Ethambutol, Indomethacin, Phenothiazine, Interferon-a, Tamoxifen, Digoxin, Nicotinic acid, Rifabutin, Sildenafil, Vardenafil, Canthaxanthin, Gabapentin, Amiodarone, Nefazodone, Retinoids Bad compliance Concomitant participation in a pharmaceutical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Independence of the distance visual acuity with the projection spectactles of refractive errors | — |
Secondary
| Measure | Time frame |
|---|---|
| Influential factors of double vision while using the projection spectacles | — |
Countries
Germany
Contacts
Public ContactUlrike Kaiser
Zentrum für Augenheilkunde des Universitätsklinikums Essen
Outcome results
None listed